Zhong Hua Jiu Patch

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for topical application in specific dermatological conditions. It is essential to avoid contact with the eyes during use. The drug should not be applied to wounds or damaged skin, and it is advised not to bandage the area tightly after application. Additionally, the drug should not be used one hour before or after bathing to ensure optimal effectiveness.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

For adults and children aged 12 years and older, the recommended administration involves the following steps: First, remove the patch from its protective layer. The patch should then be applied directly to the affected area, followed by gentle rubbing of the area with the hand to ensure secure adhesion. Each patch is designed to remain effective for a duration of 12 hours and is most effective when applied one hour after bathing. It is important to note that the patch should not be left on the same spot for more than 12 hours. Additionally, the patch should not be applied to areas with excessive hair, as the adhesive may cause discomfort upon removal.

For children under 12 years of age, the use of this product is not recommended. Consultation with a healthcare professional is advised for any questions or concerns regarding its use in this age group.

Contraindications

Use of this product is contraindicated in patients with wounds, irritated or damaged skin, and sensitive skin. Application in these conditions may exacerbate irritation or cause further skin damage.

Warnings and Precautions

FOR EXTERNAL USE ONLY.

It is imperative to keep this product out of reach of children to prevent accidental poisoning. The product should not be applied to wounds, irritated or damaged skin, or sensitive skin areas to avoid adverse reactions.

Healthcare professionals should advise patients to discontinue use and consult a physician if any of the following occur: the condition worsens, symptoms persist for more than seven days, symptoms resolve and then recur within a few days, excessive skin irritation or burning develops, or if redness is observed. These precautions are essential to ensure patient safety and effective management of symptoms.

Side Effects

Patients using this product should be aware that it is intended for external use only. In the event that the condition worsens, or if symptoms persist for more than seven days, it is advised to stop use and consult a healthcare professional. Additionally, if symptoms clear up and then recur within a few days, or if excessive irritation of the skin or burning sensation develops, patients should seek medical advice. The presence of redness is also a reason to discontinue use and consult a doctor.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Zhong Hua Jiu Patch (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this product and should consult a doctor for appropriate alternatives. For adolescents aged 12 years and older, the recommended application involves removing the patch from the protective layer, applying it to the affected area, and rubbing the area with the hand to ensure the patch is secured.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients are advised to consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and it is recommended that it not be used unless directed by a healthcare provider. Women of childbearing potential should be aware of the potential risks and should seek medical advice to ensure appropriate management during pregnancy.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any considerations related to lactation. Therefore, healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the effects on breastfed infants are not well characterized. It is advisable to monitor breastfed infants for any potential adverse effects if the medication is administered to nursing mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, it is important for healthcare professionals to remain vigilant and consider general principles of management in cases of suspected drug overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved. Common symptoms may include, but are not limited to, altered mental status, respiratory depression, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate assessment of the patient's airway, breathing, and circulation is crucial. Supportive care should be initiated as necessary, and specific antidotes should be administered if available and indicated.

Healthcare professionals are advised to consult local poison control centers or relevant clinical guidelines for further management strategies tailored to the specific substance involved in the overdose. Continuous monitoring and supportive care are essential components of effective management in these situations.

Documentation of the incident, including the substance involved, estimated dose, time of exposure, and any symptoms observed, is critical for ongoing care and potential reporting requirements.

Nonclinical Toxicology

If pregnant, it is advised to consult a health professional before use. There are no specific non-teratogenic effects or nonclinical toxicology details available. Additionally, no specific information regarding animal pharmacology and toxicology has been provided.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental poisoning. It is important to inform patients that the product should not be used on wounds, irritated or damaged skin, or sensitive skin areas.

Patients should be instructed to stop using the product and consult a doctor if their condition worsens or if symptoms persist for more than seven days. Additionally, they should be made aware that if symptoms clear up and then reoccur within a few days, they should also seek medical advice.

Healthcare providers should emphasize that patients need to discontinue use and contact a doctor if they experience excessive irritation of the skin, burning sensations, or if redness is present. This guidance is crucial for ensuring patient safety and effective use of the product.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers. It should be stored at room temperature, within the range of 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit). Proper storage conditions are essential to maintain the integrity of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Zhong Hua Jiu Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)